Subcutaneous Injection
Subcutaneous (SC or SubQ) injection delivers a substance into the subcutaneous tissue layer between the dermis and the muscle fascia. In research models, this route provides slower absorption than intravenous or intramuscular delivery, creating a depot effect.
Many published peptide studies use subcutaneous administration in animal models. The subcutaneous route is commonly employed in rodent studies for BPC-157, TB-500, GLP-1 agonists, and growth hormone secretagogues. Clinical trials of semaglutide, tirzepatide, and tesamorelin have used subcutaneous injection as the administration route.
This glossary entry describes a research methodology. All Healthy Aminos products are for research use only and are not intended for injection into humans.
Related Products
Related Terms
Bioavailability
The fraction of an administered compound that reaches systemic circulation in an active form, influenced by route of administration and molecular properties.
Half-Life
The time required for the concentration of a compound to decrease by 50%, a key pharmacokinetic parameter in peptide research.
In Vivo
Research conducted within a living organism, such as animal models, to study biological processes in their natural context.
Preclinical
The stage of research conducted before human clinical trials, encompassing in vitro studies and animal model experiments.
Research Use Only
FOR RESEARCH USE ONLY. Products sold by Healthy Aminos are intended strictly for in-vitro research and laboratory use. Not for human or animal consumption. Not FDA approved. By purchasing from Healthy Aminos, the buyer acknowledges that these products are not intended to diagnose, treat, cure, or prevent any disease. All products are sold as reference standards and research chemicals only.